Blurbs

Analysts Offer Insights on Healthcare Companies: AstraZeneca (AZN), Ayr Wellness (OtherAYRWF) and Privia Health Group (PRVA)

Analysts have been eager to weigh in on the Healthcare sector with new ratings on AstraZeneca (AZNResearch Report), Ayr Wellness (AYRWFResearch Report) and Privia Health Group (PRVAResearch Report).

AstraZeneca (AZN)

In a report released today, Andrew Berens from SVB Securities maintained a Buy rating on AstraZeneca, with a price target of $78.00. The company’s shares closed last Thursday at $65.09.

According to TipRanks.com, Berens is a 4-star analyst with an average return of 3.7% and a 46.6% success rate. Berens covers the Healthcare sector, focusing on stocks such as Deciphera Pharmaceuticals, Zentalis Pharmaceuticals, and Theseus Pharmaceuticals.

AstraZeneca has an analyst consensus of Moderate Buy, with a price target consensus of $76.50.

See today’s best-performing stocks on TipRanks >>

Ayr Wellness (AYRWF)

In a report released today, Pablo Zuanic from Cantor Fitzgerald maintained a Hold rating on Ayr Wellness, with a price target of $4.25. The company’s shares closed last Thursday at $3.39, close to its 52-week low of $2.30.

According to TipRanks.com, Zuanic is ranked #1420 out of 8077 analysts.

Currently, the analyst consensus on Ayr Wellness is a Strong Buy with an average price target of $11.79.

Privia Health Group (PRVA)

SVB Securities analyst Whit Mayo maintained a Buy rating on Privia Health Group today and set a price target of $39.00. The company’s shares closed last Thursday at $28.53.

According to TipRanks.com, Mayo is a 4-star analyst with an average return of 5.9% and a 57.1% success rate. Mayo covers the Healthcare sector, focusing on stocks such as Airsculpt Technologies, Inc., Alignment Healthcare, and Acadia Healthcare.

Privia Health Group has an analyst consensus of Strong Buy, with a price target consensus of $45.13, a 73.4% upside from current levels. In a report released today, Canaccord Genuity also maintained a Buy rating on the stock with a $43.00 price target.

TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.

Read More on AZN:

Tired of arriving late to the Big Returns Party?​
Most investors don’t have major gainers like TSLA or NVDA on their radar from the start.
The profusion of opinions on social media and financial blogs makes it impossible to distinguish between real growth potential and pure hype.
​​For the past decade, we have developed and perfected technology designed to help private investors, just like you, find the best opportunities, with the greatest upside potential, in any financial climate.​
Learn More